Half Moon Bay, CA, United States of America

Drake LaFace

USPTO Granted Patents = 5 

Average Co-Inventor Count = 5.6

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2012-2025

Loading Chart...
5 patents (USPTO):

Title: Drake LaFace: Innovator in Cancer Therapy

Introduction

Drake LaFace is a prominent inventor based in Half Moon Bay, CA (US). He has made significant contributions to the field of cancer therapy, holding a total of 5 patents. His work focuses on innovative combination therapies that target critical pathways in cancer treatment.

Latest Patents

Among his latest patents are groundbreaking inventions such as "Anti-cancer combination therapies comprising CTLA-4 and PD-1 blocking agents." This patent discloses combination therapies that utilize an effector-silent anti-CTLA-4 antibody or fragment alongside an anti-PD-1 or anti-PD-L1 antibody. Another notable patent is for "Anti-TIGIT antibodies," which relates to the use of these antibodies in treating diseases like cancer and infectious diseases.

Career Highlights

Drake LaFace has worked with renowned companies in the pharmaceutical industry, including Merck Sharp & Dohme Corporation and Schering Corporation. His experience in these organizations has allowed him to develop and refine his innovative approaches to cancer treatment.

Collaborations

Drake has collaborated with notable professionals in his field, including Sybil M G Williams and Laurence Fayadat-Dilman. These collaborations have further enhanced his research and development efforts.

Conclusion

Drake LaFace is a key figure in the advancement of cancer therapies, with a focus on innovative combination treatments. His contributions to the field are significant and continue to impact the landscape of cancer treatment.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…